BACKGROUND For over two decades, a racemic mixture of oxamniquine (OXA) was administered to patients infected by Schistosoma mansoni, but whether one or both enantiomers exert antischistosomal activity was unknown. Recently, a ~30 kDa S. mansoni sulfotransferase (SmSULT) was identified as the target of OXA action. METHODOLOGY/PRINCIPAL FINDINGS Here, we separate the OXA enantiomers using chro...

conclusions the high prevalence of oxa β-lactamase and high genetic diversity of p. aeruginosa indicated that the resistance of p. aeruginosa might be expanding in our studied hospitals. background pseudomonas aeruginosa is main bacterial pathogen accountable for nosocomial infections. furthermore, it could potentially become resistant to β-lactams, aminoglycosides and fluoroquinolones antibiot...

The genus Acinetobacter comprises several groups of closely related species, including the Acinetobacter calcoaceticus-Acinetobacter baumannii complex (1) and a number of hemolytic species (2). Currently, the A. calcoaceticus-A. baumannii complex comprises five validly named species, including A. calcoaceticus, A. baumannii, A. pittii, and A. nosocomialis (3); the recently named species A. seif...

INTRODUCTION bla(OXA-48) is a globally emerging carbapenemase-encoding gene. The progenitor of bla(OXA-48) appears to be a Shewanella species. The presence of the bla(OXA-48)-like gene was investigated for two Shewanella xiamenensis strains. METHODS Strain WCJ25 was recovered from post-surgical abdominal drainages, while S4 was the type strain of S. xiamenensis. Species identification for WCJ...

Background: This study aimed to evaluate the role of efflux pump regulator and OXA-23 genes in imipenem resistance Acinetobacter baumannii strains isolated from hospitalized patients in Tehran, Iran. Methods: This study was conducted on 60 A. baumannii isolates collected from pa...

BACKGROUND Multidrug-resistant strains of Acinetobacter baumannii have been reported increasingly around the world. The administration of an association of antibiotics has been proposed to create an active combination and to prevent the emergence of resistance. METHODOLOGY The activity of colistin, rifampicin, gentamicin, imipenem and their associations was evaluated by means of killing curve...

The sulbactam resistance rate in Acinetobacter baumannii has increased worldwide. Previous reports have shown that the β-lactamase bla TEM-1 confers resistance to sulbactam in A. baumannii. The purpose of this study was to examine whether other β-lactamases, including the Acinetobacter-derived cephalosporinase (ADC), OXA-23, OXA-24/72, and OXA-58 families, also contribute to sulbactam resistanc...

Acinetobacter baumannii strains resistant to all -lactams, aminoglycosides, and fluoroquinolones have emerged in many medical centers. Potential mechanisms contributing to antimicrobial resistance were investigated in 40 clinical isolates endemic to New York City. The isolates were examined for the presence of various -lactamases, aminoglycoside-modifying enzymes, and mutations in gyrA and parC...

Acinetobacter baumannii is an important nosocomial pathogen occurring particularly in intensive care (ICU) as well as burn therapy units (BTU). A. baumannii strains have emerged as resistant to almost all antimicrobial agents, including carbapenems. b-lactamase-mediated resistance is the most common mechanism for carbapenem resistance in this species. Carbapenem-hydrolysing class D b-lactamases...